Blake Insomnia Therapeutics is a pharmaceutical company. The company operates as a provider of insomnia remedy. Blake Insomnia is focused on developing its business plan for an insomnia medication known as Zleepax. Zleepax is a sleep aid with beta blockers as an active agent.
Type
Public
HQ
New York, US
Founded
2012
Size (employees)
6 (est)
Blake Insomnia Therapeutics was founded in 2012 and is headquartered in New York, US
Report incorrect company information

Blake Insomnia Therapeutics Office Locations

Blake Insomnia Therapeutics has an office in New York
New York, US (HQ)
154 244 5th Ave
Show all (1)
Report incorrect company information

Blake Insomnia Therapeutics Financials and Metrics

Blake Insomnia Therapeutics Financials

Market capitalization (31-Oct-2017)

2.8 m

Closing share price (31-Oct-2017)

0.1
Blake Insomnia Therapeutics's current market capitalization is $2.8 m.
Show all financial metrics
Report incorrect company information